Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.

Background: A vaccine against SARS-CoV-2 for children and adolescents will play an important role in curbing the COVID-19 pandemic. Here we aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing inactivated SARS-CoV-2, in children and adol...

Descripción completa

Detalles Bibliográficos

Publicado en:	Lancet Infectious Diseases Vol. 21; no. 12; pp. 1645 - 1654
Autores principales:	Han, Bihua, Song, Yufei, Li, Changgui, Yang, Wanqi, Ma, Qingxia, Jiang, Zhiwei, Li, Minjie, Lian, Xiaojuan, Jiao, Wenbin, Wang, Lei, Shu, Qun, Wu, Zhiwei, Zhao, Yuliang, Li, Qi, Gao, Qiang
Formato:	research Journal Article
Publicado:	Elsevier B.V. Dec2021
Acceso en línea:	Ver este registro en EBSCOhost